首页 | 本学科首页   官方微博 | 高级检索  
     


Deubiquitinase inhibition by WP1130 leads to ULK1 aggregation and blockade of autophagy
Authors:Stefan Drie?en  Niklas Berleth  Olena Friesen  Antje S L?ffler  Philip B?hler  Nora Hieke  Fabian Stuhldreier  Christoph Peter  Kay O Schink  Sebastian W Schultz  Harald Stenmark  Petter Holland  Anne Simonsen  Sebastian Wesselborg  Bj?rn Stork
Affiliation:1.Institute of Molecular Medicine; Heinrich-Heine-University; Düsseldorf, Germany;2.Department of Biochemistry; Institute for Cancer Research; The Norwegian Radium Hospital; Oslo, Norway;3.Institute of Basic Medical Sciences; Faculty of Medicine; University of Oslo; Oslo, Norway
Abstract:Autophagy represents an intracellular degradation process which is involved in both regular cell homeostasis and disease settings. In recent years, the molecular machinery governing this process has been elucidated. The ULK1 kinase complex consisting of the serine/threonine protein kinase ULK1 and the adapter proteins ATG13, RB1CC1, and ATG101, is centrally involved in the regulation of autophagy initiation. This complex is in turn regulated by the activity of different nutrient- or energy-sensing kinases, including MTOR, AMPK, and AKT. However, next to phosphorylation processes it has been suggested that ubiquitination of ULK1 positively influences ULK1 function. Here we report that the inhibition of deubiquitinases by the compound WP1130 leads to increased ULK1 ubiquitination, the transfer of ULK1 to aggresomes, and the inhibition of ULK1 activity. Additionally, WP1130 can block the autophagic flux. Thus, treatment with WP1130 might represent an efficient tool to inhibit the autophagy-initiating ULK1 complex and autophagy.
Keywords:autophagy   deubiquitinases   ubiquitination   ULK1   WP1130
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号